Changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the Walker 256 tumor

Two variants (A and B) of the widely employed Walker 256 rat tumor cells are known. When inoculated sc, the A variant produces solid, invasive, highly metastasizing tumors that cause severe systemic effects and death. We have obtained a regressive variant (AR) whose sc growth is slower, resulting in 70-80% regression followed by development of immunity against A and AR variants. Simultaneously with the beginning of tumor regression, a temporary anemia developed (~8 days duration), accompanied by marked splenomegaly (~300%) and changes in red blood cell osmotic fragility, with mean corpuscular fragility increasing from 4.1 to 6.5 g/l NaCl. The possibility was raised that plasma factors associated with the immune response induced these changes. In the present study, we identify and compare the osmotic fragility increasing activity of plasma fractions obtained from A and AR tumor bearers at different stages of tumor development. The results showed that by day 4 compounds precipitating in 60% (NH4)2SO4 and able to increase red blood cell osmotic fragility appeared in the plasma of A and AR tumor bearers. Later, these compounds disappeared from the plasma of A tumor bearers but slightly increased in the plasma of AR tumor bearers. Furthermore, by day 10, compounds precipitating between 60 and 80% (NH4)2SO4 and with similar effects appeared only in plasma of AR tumor bearers. The salt solubility, production kinetics and hemolytic activity of these compounds resemble those of the immunoglobulins. This, together with their preferential increase in rats bearing the AR variant, suggest their association with an immune response against this tumor.

Saved in:
Bibliographic Details
Main Authors: Cavalcanti,T.C., Gregorini,C.C., Guimarães,F., Rettori,O., Vieira-Matos,A.N.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2003
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2003000700009
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2003000700009
record_format ojs
spelling oai:scielo:S0100-879X20030007000092003-06-26Changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the Walker 256 tumorCavalcanti,T.C.Gregorini,C.C.Guimarães,F.Rettori,O.Vieira-Matos,A.N. Plasma fractions Temporary anemia RBC osmotic fragility Tumor regressive variant Cancer immunity Walker 256 tumor Two variants (A and B) of the widely employed Walker 256 rat tumor cells are known. When inoculated sc, the A variant produces solid, invasive, highly metastasizing tumors that cause severe systemic effects and death. We have obtained a regressive variant (AR) whose sc growth is slower, resulting in 70-80% regression followed by development of immunity against A and AR variants. Simultaneously with the beginning of tumor regression, a temporary anemia developed (~8 days duration), accompanied by marked splenomegaly (~300%) and changes in red blood cell osmotic fragility, with mean corpuscular fragility increasing from 4.1 to 6.5 g/l NaCl. The possibility was raised that plasma factors associated with the immune response induced these changes. In the present study, we identify and compare the osmotic fragility increasing activity of plasma fractions obtained from A and AR tumor bearers at different stages of tumor development. The results showed that by day 4 compounds precipitating in 60% (NH4)2SO4 and able to increase red blood cell osmotic fragility appeared in the plasma of A and AR tumor bearers. Later, these compounds disappeared from the plasma of A tumor bearers but slightly increased in the plasma of AR tumor bearers. Furthermore, by day 10, compounds precipitating between 60 and 80% (NH4)2SO4 and with similar effects appeared only in plasma of AR tumor bearers. The salt solubility, production kinetics and hemolytic activity of these compounds resemble those of the immunoglobulins. This, together with their preferential increase in rats bearing the AR variant, suggest their association with an immune response against this tumor.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.36 n.7 20032003-07-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2003000700009en10.1590/S0100-879X2003000700009
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Cavalcanti,T.C.
Gregorini,C.C.
Guimarães,F.
Rettori,O.
Vieira-Matos,A.N.
spellingShingle Cavalcanti,T.C.
Gregorini,C.C.
Guimarães,F.
Rettori,O.
Vieira-Matos,A.N.
Changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the Walker 256 tumor
author_facet Cavalcanti,T.C.
Gregorini,C.C.
Guimarães,F.
Rettori,O.
Vieira-Matos,A.N.
author_sort Cavalcanti,T.C.
title Changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the Walker 256 tumor
title_short Changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the Walker 256 tumor
title_full Changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the Walker 256 tumor
title_fullStr Changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the Walker 256 tumor
title_full_unstemmed Changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the Walker 256 tumor
title_sort changes in red blood cell osmotic fragility induced by total plasma and plasma fractions obtained from rats bearing progressive and regressive variants of the walker 256 tumor
description Two variants (A and B) of the widely employed Walker 256 rat tumor cells are known. When inoculated sc, the A variant produces solid, invasive, highly metastasizing tumors that cause severe systemic effects and death. We have obtained a regressive variant (AR) whose sc growth is slower, resulting in 70-80% regression followed by development of immunity against A and AR variants. Simultaneously with the beginning of tumor regression, a temporary anemia developed (~8 days duration), accompanied by marked splenomegaly (~300%) and changes in red blood cell osmotic fragility, with mean corpuscular fragility increasing from 4.1 to 6.5 g/l NaCl. The possibility was raised that plasma factors associated with the immune response induced these changes. In the present study, we identify and compare the osmotic fragility increasing activity of plasma fractions obtained from A and AR tumor bearers at different stages of tumor development. The results showed that by day 4 compounds precipitating in 60% (NH4)2SO4 and able to increase red blood cell osmotic fragility appeared in the plasma of A and AR tumor bearers. Later, these compounds disappeared from the plasma of A tumor bearers but slightly increased in the plasma of AR tumor bearers. Furthermore, by day 10, compounds precipitating between 60 and 80% (NH4)2SO4 and with similar effects appeared only in plasma of AR tumor bearers. The salt solubility, production kinetics and hemolytic activity of these compounds resemble those of the immunoglobulins. This, together with their preferential increase in rats bearing the AR variant, suggest their association with an immune response against this tumor.
publisher Associação Brasileira de Divulgação Científica
publishDate 2003
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2003000700009
work_keys_str_mv AT cavalcantitc changesinredbloodcellosmoticfragilityinducedbytotalplasmaandplasmafractionsobtainedfromratsbearingprogressiveandregressivevariantsofthewalker256tumor
AT gregorinicc changesinredbloodcellosmoticfragilityinducedbytotalplasmaandplasmafractionsobtainedfromratsbearingprogressiveandregressivevariantsofthewalker256tumor
AT guimaraesf changesinredbloodcellosmoticfragilityinducedbytotalplasmaandplasmafractionsobtainedfromratsbearingprogressiveandregressivevariantsofthewalker256tumor
AT rettorio changesinredbloodcellosmoticfragilityinducedbytotalplasmaandplasmafractionsobtainedfromratsbearingprogressiveandregressivevariantsofthewalker256tumor
AT vieiramatosan changesinredbloodcellosmoticfragilityinducedbytotalplasmaandplasmafractionsobtainedfromratsbearingprogressiveandregressivevariantsofthewalker256tumor
_version_ 1756391052385714176